Tailoring to RB: tumour suppressor status and therapeutic response
- 7 August 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 8 (9), 714-724
- https://doi.org/10.1038/nrc2401
Abstract
No abstract availableKeywords
This publication has 202 references indexed in Scilit:
- Life and death decisions by the E2F transcription factorsCurrent Opinion in Cell Biology, 2007
- E2F-associated chromatin modifiers and cell cycle controlCurrent Opinion in Cell Biology, 2007
- Abrogated Response to Cellular Stress Identifies DCIS Associated with Subsequent Tumor Events and Defines Basal-like Breast TumorsCancer Cell, 2007
- Impact of differential cyclin D1 expression and localisation in prostate cancerBritish Journal of Cancer, 2007
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for allNature Reviews Molecular Cell Biology, 2006
- A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancersNature Genetics, 2006
- The Concept of Synthetic Lethality in the Context of Anticancer TherapyNature Reviews Cancer, 2005
- Biological activities and molecular targets of the human papillomavirus E7 oncoproteinOncogene, 2001
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993